Koers Hemcheck Sweden AB (publ) Nasdaq Stockholm
Aandelen
SE0009320278
Medische apparatuur, benodigdheden & distributie
Omzet 2022 | 4,74 mln. 438K 407K | Omzet 2023 | 3 mln. 277K 257K | Marktkapitalisatie | 8,18 mln. 756K 702K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -14 mln. -1,29 mln. -1,2 mln. | Nettowinst (verlies) 2023 | -12 mln. -1,11 mln. -1,03 mln. | EV/omzet 2022 | 0,7 x |
Nettoliquiditeiten 2022 | 3,19 mln. 294K 274K | Nettoliquiditeiten 2023 | 3,07 mln. 284K 264K | EV/omzet 2023 | 1,7 x |
K/w-verhouding 2022 |
-0,33
x | K/w-verhouding 2023 |
-1,04
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 7,12% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joen Averstad
CEO | Chief Executive Officer | 40 | 01-01-12 |
Robert Thorén
DFI | Director of Finance/CFO | 47 | 01-01-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 50 | 01-01-10 | |
Founder | 52 | 01-01-10 | |
Director/Board Member | 65 | 01-01-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,64% | 12,65 mld. | |
-6,06% | 8,01 mld. | |
-0,64% | 5,35 mld. | |
+21,79% | 5,23 mld. | |
+2,05% | 4,69 mld. | |
-51,30% | 3,26 mld. | |
+7,80% | 2,64 mld. | |
-9,19% | 2,23 mld. | |
-0,96% | 1,94 mld. |